CD19-targeting CAR T-cell immunotherapy yields high responses in treatment-resistant CLL

Posted by on December 3, 2016 7:45 pm
Tags:
Categories: health

In a small, early phase trial, a high percentage of patients who had exhausted most traditional treatments for chronic lymphocytic leukemia saw their tumors shrink or even disappear after an infusion of a highly targeted, experimental CAR T-cell immunotherapy.

Leave a Reply

Your email address will not be published. Required fields are marked *